CLINICAL PRESENTATION AND OUTCOMES OF SOLITARY PLASMACYTOMA IN A LARGE TERTIARY HOSPITAL: A RETROSPECTIVE COHORT STUDY.

EHA Library, Charles AGBUDUWE, 268049

POST-TREATMENT IMMUNE RECONSTITUTION IN MYELOMA IS ASSOCIATED WITH IMPROVED PROGRESSION FREE SURVIVAL IN THE ERA OF NOVEL THERAPY; A RETROSPECTIVE ANALYSIS IN AN AUSTRALIAN HAEMATOLOGY DEPARTMENT

EHA Library, Shivam Agrawal, 268050

VELCADITO. A PHASE II TRIAL WITH LOW DOSES OF BORTEZOMIB PLUS MELPHALAN AND PREDNISONE FOR ELDERLY PATIENTS (>75Y) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Ernesto Pérez Persona, 268051

THE IMPACT OF RVD OR VCD INDUCTION ON RESPONSE 3 MONTH AFTER FIRST LINE AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MYELOMA. A SINGLE_CENTER RETROSPECTIVE ANALYSIS.

EHA Library, Jakob Nordberg Nørgaard, 268052

SYMPTOM BURDEN AND OXIDATIVE STRESS IN MULTIPLE MYELOMA PATIENTS IN EARLY POST-TRANSPLANTATION PERIOD

EHA Library, Anastasiia Zherniakova, 268053

BORTEZOMIB-HIGH DOSE METHYLPREDNISOLONE OFFERS IMPROVED HAEMATOLOGICAL RESPONSES AND OVERALL SURVIVAL COMPARED TO BORTEZOMIB-DEXAMETHASONE IN SYSTEMIC LIGHT CHAIN AMYLOIDOSIS

EHA Library, Ayesha Shameem Mahmood, 268054

PRETREATMENT D-DIMER LEVELS PROVIDE PROGNOSTIC INFORMATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Peipei Xu, 268055

REAL-WORLD ITALIAN EXPERIENCE OF POMALIDOMIDE IN RELAPSED-REFRACTORY MYELOMA: RETROSPECTIVE MULTICENTER STUDY BY THE RETE EMATOLOGICA PUGLIESE AND BASILICATA

EHA Library, Giuseppe Mele, 268056

CTDA VERSUS MPT FOR MULTIPLE MYELOMA: REAL WORLD DATA FROM THE WEST OF SCOTLAND CANCER NETWORK

EHA Library, Matt Steel, 268057

DARATUMUMAB MONOTHERAPY FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA REAL CLINICAL PRACTICE. A MULTICENTRIC RETROSPECTIVE STUDY.

EHA Library, Alvaro Lorenzo Vizcaya, 268058

THE IMPACT OF COMORBIDITY ON OVERALL SURVIVAL IN MULTIPLE MYELOMA

EHA Library, Evgeniy Mikhailov, 268059

VALIDATION OF THE BOSTON UNIVERSITY STAGING SYSTEM IN AL AMYLOIDOSIS

EHA Library, Peter Mollee, 268060

DO FUNCTIONAL VARIANTS OF MIF AND MBL GENES INFLUENCE OUTCOME IN PATIENTS UNDERWENT AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA?

EHA Library, Mustafa Pehlivan, 268061

LIGHT CHAIN (AL) AMYLOIDOSIS: A SINGLE CENTRE EXPERIENCE AND THE EFFECTIVENESS OF BORTEZOMIB BASED THERAPY AS FIRST LINE THERAPY

EHA Library, Henry Ngu, 268062

IMPACT OF OVERWEIGHT IN TREATMENT WITH DARATUMUMAB IN MULTIPLE MYELOMA PATIENTS

EHA Library, Adriana Roque, 268063

IMPACT OF EXTRAMEDULLARY DISEASE IN THE OUTCOMES OF MEXICAN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Ana Cesar, 268064

FEATURES OF THE DIRECT ANTIGLOBULIN TEST IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Elena Poponina, 268065

BUSULFAN/CYCLOPHOSPHAMIDE (BU/CY) COMPARED WITH HIGH-DOSE MELPHALAN (HDMEL) AS CONDITIONING REGIMEN FOR AUTO STEM CELL TRANSPLANTATION OF MULTIPLE MYELOMA

EHA Library, Zhengzheng Fu, 268066

HEPATITIS B VIRUS INFECTION MIGHT CONTRIBUTE TO MULTIPLE MYELOMA PROGRESSION THROUGH 1Q21 AMPLIFICATION

EHA Library, Peipei Xu, 268067

POMALIDOMIDE AND DEXAMETHASONE IN RELAPSING POEMS SYNDROME: A FRENCH REPORT OF 5 CASES.

EHA Library, Camille GOLFIER, 268068

SINGLE AGENT DARATUMUMAB IN VERY ADVANCED RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: A REAL-LIFE SINGLE CENTER RETROSPECTIVE STUDY

EHA Library, Maxime Jullien, 268069

AL AMYLOIDOSIS IN THE CHILEAN PUBLIC HEALTH SYSTEM: A PENDING DEBT. MULTICENTER STUDY OF THE CHILEAN HEMATOLOGICAL COOPERATIVE GROUP (PANDA).

EHA Library, Hernan Lopez Vidal, 268070

NUMBER OF INVOLVED BONE REGIONS IS A SIMPLE AND USEFUL PREDICTIVE MARKER OF EARLY DISEASE PROGRESSION AND DEATH IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

EHA Library, Katsuya Fujimoto, 268071

EFFICACY AND SAFETY OF THE ANTITUMOR RVP PROGRAM (LENALIDOMIDE, BORTEZOMIB, PREDNISONE) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Кирилл Белоусов, 268072

HEPATITIS B VIRUS INFECTION MIGHT CONTRIBUTE TO MULTIPLE MYELOMA PROGRESSION THROUGH 1Q21 AMPLIFICATION

EHA Library, Peipei Xu, 268073

THE ROLE OF THE BONE MARROW MICROENVIRONMENT AND CYTOKINES IN THE PROGRESSION OF MONOCLONAL GAMMAPATHY AND MULTIPLE MYELOMA IN PATIENTS OF THE GOMEL REGION OF BELARUS

EHA Library, Zhanna Kozich, 268074

MENTAL HEALTH AND QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE

EHA Library, Yasushi Hiramatsu, 268075

ONLINE CME SIGNIFICANTLY IMPACTS MULTIPLE MYELOMA CLINICIANS: EXPERIENCE FROM A MULTI-YEAR CURRICULUM WITH 33,699 LEARNERS

EHA Library, Lauren Willis, 268076

RISK FACTORS ASSOCIATED WITH EARLY MORTALITY IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Anna Novikova, 268077

CHARACTERISTICS AND REAL-WORLD TREATMENT OUTCOMES IN MULTIPLE MYELOMA YOUNG PATIENTS: A SINGLE CENTER MOROCCAN EXPERIENCE

EHA Library, Mahtat EL MEHDI, 268078

POMALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (PCD) IS AN EFFECTIVE SALVAGE REGIMEN FOR MULTIPLE MYELOMA (MM) PATIENTS RELAPSED ON OR REFRACTORY TO DARATUMUMAB

EHA Library, Annamaria Brioli, 268079

CHOLESTEROL LEVELS PROVIDE PROGNOSTIC INFORMATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Peipei Xu, 268080

REAL LIFE EXPERIENCE OF TREATMENT WITH POMALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE COMBINATION IN ADULT PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA

EHA Library, Carolina ALARCÓN-PAYER, 268081

INCIDENCE & SEVERITY OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY WITH THE USE OF GENERIC BORTEZOMIB IN MONOCLONAL GAMMOPATHIES: A PROSPECTIVE STUDY FROM INDIA

EHA Library, Uttam Kumar Nath, 268082

CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE “ON DEMAND” IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: REAL LIFE EXPERIENCE AND NEW PERSPECTIVES ON DOSE-DENSE CHEMOTHERAPY.

EHA Library, Antonio Giordano, 268083

PROGNOSTIC VALUE OF SERUM FREE LIGHT CHAIN IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Наталия Скворцова, 268084

SUPERIOR AUTOMATED MAGNETIC ISOLATION OF PLASMA CELLS FROM MYELOMA BONE MARROW YIELDING HIGH-QUALITY CELLS FOR DOWNSTREAM PROCESSING

EHA Library, Daniela Vorholt, 268086

EPIDEMIOLOGICAL DATA ON MULTIPLE MYELOMA IN KOSOVO BETWEEN 2009 - 2018

EHA Library, Viola Cavolli, 268087

OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA; EXPERIENCE FROM A SINGLE CENTER IN SAUDI ARABIA

EHA Library, Giamal Edin Gmati, 268088

18F-FDG PET/CT IN PATIENTS WITH MULTIPLE MYELOMA AFTER STEM CELLS TRANSPLANTATION.

EHA Library, Alexeev Sergey, 268089

HEPATITIS C VIRUS-DRIVEN MULTIPLE MYELOMA IN STABLE COMPLETE REMISSION AFTER ANTIVIRAL TREATMENT

EHA Library, Alba Rodríguez-García, 268090

THE COMPARISON OF THE RELATIONSHIP BETWEEN POLYNEUROPATHY FREQUENCY AND CLINICAL AND LABORATORY FINDINGS IN MULTIPLE MYELOMA CASES

EHA Library, Aysun SENTURK YIKILMAZ, 268091

THE EFFECTS OF CURCUMIN ADDITION ON REMISSION STATUS OF MULTIPLE MYELOMA PATIENTS

EHA Library, Damai santosa, 268092

OUTCOMES AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: IMPACT OF RENAL FAILURE

EHA Library, Rym El Fatmi, 268093

LONG TERM FOLLOW-UP OF MAINTENANCE THERAPY WITH INTEREFRON ALPHA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT IN MULTIPLE MYELOMA PATIENTS –SINGLE CENTER EXPERIENCE

EHA Library, Josip Batinić, 268094

IMMUNOGLOBULIN D MULTIPLE MYELOMA IN THE ERA OF BORTEZOMIB-BASED REGIMENS: A SINGLE CENTER EXPERIENCE.

EHA Library, Lucia Ciuffreda, 268095

MULTIPLE MYELOMA IN PATIENTS UNDER 65 YEARS: AN ANALYSIS OF 56 CASES FROM SANATORIO DEL SALVADOR IN CORDOBA, ARGENTINA

EHA Library, Daiana Rodriguez, 268096

THROMBOEMBOLIC EVENTS IN MULTIPLE MYELOMA (MM) PATIENTS. A SINGLE CENTER RETROSPECTIVE STUDY.

EHA Library, Maria Stefania Infante, 268097

EXPERIENCE VRD-PACE-LIKE REGIMEN IN PATIENTS WITH PRIMARY REFRACTORY MYELOMA FOR PERIPHERAL STEM CELL MOBILIZATION

EHA Library, Islam Nakastoev, 268098

THE ROLE OF 18F-FDG PET/CT IN THE INITIAL DIAGNOSIS AND STAGING OF PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Ilina Micheva, 268099

SUPERIORITY OF CYBORD OVER VAD IS MORE EVIDENT IN FIRST THAN IN SECOND LINE TREATMENT OF MULTIPLE MYELOMA

EHA Library, Mosaad El Gammal, 268100

CARFILZOMIB OR POMALIDOMIDE IN PATIENTS WITH RELAPSE AND/OR REFRACTORY MULTIPLE MYELOMA: SINGLE CENTER EXPERIENCE

EHA Library, Aysenur Arslan, 268101

IMPACT OF CYTOGENETIC ABNORMALITIES ON RESPONSE IN A COHORT OF INDIAN MULTIPLE MYELOMA PATIENTS – IS 13Q DELETION THE NEW 17P IN DISGUISE?

EHA Library, Sumeet Mirgh, 268102

SURGICAL TREATMENT OF BONE DISEASE IN MULTIPLE MYELOMA PATIENTS.

EHA Library, Dariusz Szczepanek, 268103

FREE LIGHT CHAINS IN MULTIPLE MYELOMA: IS IT TIME TO EXTEND THEIR APPLICATION?

EHA Library, Uros Markovic, 268104

ANALYSIS OF SALIVA SAMPLES AND CD3+ LYMPHOCYTES AS A SOURCE OF GERMINAL DNA IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Nieves Garcia-Gisbert, 268105

GLOBAL COAGULATION CAPACITY OF ESSENTIAL THROMBOCYTHEMIA PATIENTS BY ROTEM ANALYSIS ADJUSTED FOR PLATELET COUNT CORRELATES WITH THROMBOTIC RISK CLASS

EHA Library, Cinzia Giaccherini, 268106

GENE EXPRESSION PROFILE IN PRIMARY MYELOFIBROSIS: ROLE OF ASXL1

EHA Library, Santiago Sánchez Sosa, 268107

DE-REGULATION OF MIRNAS DURING TREATMENT OF PATIENTS AFFECTED BY MYELOFIBROSIS WITH RUXOLITINIB.

EHA Library, Sara Galimberti, 268108

ASSESSMENT OF PLATELET MEMBRANE ALTERATION IN PATIENTS WITH MYELOID METAPLASIA WITH MYELOFIBROSIS

EHA Library, Viola Popov, 268109

ANTIPLATELET THERAPY IN ESSENTIAL THROMBOCYTHEMIA: LABORATORY STUDY OF LOW-DOSE ASPIRIN.

EHA Library, Rossella Cacciola, 268110

NEXT-GENERATION SEQUENCING IN CLINICAL PRACTICE: MOLECULAR EVENTS AND COURSE OF MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Liubov Poluskina, 268111

MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE?

EHA Library, Marco Santoro, 268112

PROGRESS AND SURVIVAL IN TRIPLE NEGATIVE PRIMARY MYELOFIBROSIS PATIENTS

EHA Library, Potre Cristina, 268113

VALIDATION OF THE PRIMERDESIGN® QUANTITATIVE ALLELE SPECIFIC AMPLIFICATION KIT FOR THE DETECTION OF THE JAK2V617F MUTATION

EHA Library, Deborah Vaz, 268114

IMPROVEMENT OF THE HEMATOLOGIC TOXICITIES OF RUXOLITINIB IN PATIENTS WITH MPN-ASSOCIATED MYELOFIBROSIS USING A COMBINATION OF THALIDOMIDE, STANOZOLOL AND PREDNISONE

EHA Library, Minghui Duan, 268115

SERUM YKL-40 LEVELS ARE ELEVATED IN PRIMARY AND SECONDARY MYELOFIBROSIS AND MAY BE AFFECTING THEIR SURVIVAL

EHA Library, Ivan Krecak, 268116

HEMOSTATIC MARKERS OF HYPERCOAGULABILITY IN PRIMARY MYELOFIBROSIS PATIENTS, RELATION WITH JAK2V617F ALLELE BURDEN

EHA Library, Natalia Korsakova, 268117

EARLY SPLEEN RESPONSE IS A GOOD PROGNOSTIC FACTOR OF RUXOLINIB OUTCOME IN PATIENTS WITH MYELOFIBROSIS

EHA Library, Elza Lomaia, 268118

MOLECULAR PROFILE AND TELOMERE LENGTH ARE USEFUL MARKERS FOR DIFFERENTIAL DIAGNOSIS OF PRE-FIBROTIC PRIMARY MYELOFIBROSIS VERSUS ESSENTIAL THROMBOCYTHEMIA

EHA Library, Jiwon Yun, 268119

IMPACT OF SMOKING ON JAK2V617F ALLELE BURDEN AMONG PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS TREATED WITH PEGYLATED INTERFERON ALPHA-2 OR HYDROXYUREA IN THE DALIAH TRIAL

EHA Library, Dustin Patel, 268120

FACING ERYTHROCYTOSIS: RESULTS OF AN INTERNATIONAL PHYSICIANS’ SURVEY

EHA Library, Elisa Rumi, 268121

SPLANCHNIC VEIN THROMBOSIS IN MYELOPROLOFERATIVE NEOPLASMS; A PROSPECTIVE ANALYSIS OF THROMBOSIS OUTCOME.

EHA Library, Anicee Danaee, 268122

INFLAMMATORY BIOMARKERS IN PHILADELPHIA-NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS AND THE IMPACT OF SMOKING

EHA Library, Vibe Skov, 268123

HOW TO PREDICT RESPONSE TO RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS.

EHA Library, Marta Reinoso Segura, 268124

ARTERIAL AND VENOUS THROMBOSIS IN TREATED PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Ana BOBAN, 268125

EPIDEMIOLOGICAL, CLINICAL, MOLECULAR AND GENETIC CHARACTERISTICS OF PRIMARY MYELOFIBROSIS IN THE RUSSIAN FEDERATION.

EHA Library, Irina Soubortseva, 268126

MONITORING OF BIOCHEMICAL PARAMETERS AND THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Evica Simonovic, 268127

EFFECTS OF SYSTEMIC MASTOCYTOSIS ON BONE HEALTH IN SOUTH-EAST SCOTLAND

EHA Library, Nicholas peters, 268128

OVEREXPRESSION OF PRV1 GENE IN MYELOID NEOLASMS AND ASSOCIATION WITH OTHER MOELCUALR ABNORMALITIES

EHA Library, Vera STOEVA, 268129

EFFICACY AND SAFETY OF ANAGRELIDE AS A FIRST-LINE DRUG IN CYTOREDUCTIVE TREATMENT-NAÏVE ET PATIENTS IN A REAL WORLD SETTING

EHA Library, Yoshinori Hashimoto, 268130

INTERFERON THERAPY FOR PREGNANT PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS IN JAPAN

EHA Library, Yoko Edahiro, 268131

POLYCYTHEMIA VERA: A DIAGNOSTIC CHALLENGE

EHA Library, Ahmet Kursad Gunes, 268132

ARTIFICIAL INTELLIGENCE AIDING IN DIAGNOSIS OF JAK2 V617F NEGATIVE PATIENTS WITH WHO DEFINED ESSENTIAL THROMBOCYTHEMIA

EHA Library, Matjaz Sever, 268133

PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS, CLINICAL MANIFESTATION AND OUTCOME. EXPERIENCE AT HOSPITAL ITALIANO DE BUENOS AIRES.

EHA Library, Roxana aguilar, 268134

DISEASE CHARACTERISTICS AND RESPONSE TO TREATMENT OF PATIENTS WITH MYELOFIBROSIS:A MULTICENTRE DESCRIPTIVE, RETROSPECTIVE STUDY FROM SRI LANKA

EHA Library, Durgadevi Moratuwagama, 268136

THE MYELOPROLIFERATIVE NEOPLASMS UNCLASSIFIABLE. OUR EXPERIENCE.

EHA Library, Vincenzo Accurso, 268137

THE NATURAL ANTICOAGULANTS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Elizaveta Efremova, 268138

RUXOLITINIB IN POLYCYTHEMIA VERA PATIENTS: RESPONSE DIFFERENCES BETWEEN IN HYDROXYUREA INTOLERANT AND RESISTANT PATIENTS

EHA Library, Elena González Pérez, 268139

MUTATIONAL SIGNATURES AFFECT THE PHENOTYPIC PRESENTATION OF DISEASE SUBTYPES IN MPN PATIENTS FROM BOSNIA AND HERZEGOVINA

EHA Library, Erna Islamagic, 268140

SYMPTOM BURDEN AND SPLEEN SIZE RESPONSE WITH RUXOLUTINIB IN A REAL-LIFE TURKISH COHORT

EHA Library, Tulin Tuglular, 268141

APPLICATION OF HETERODUPLEX ANALYSIS FOR CARL MUTATION DETECTION

EHA Library, Tatiana Subbotina, 268142

THE RED BLOOD CELL COUNT AND THE SEDIMENTATION RATE IN THE DIAGNOSIS OF POLYCYTHAEMIA VERA?

EHA Library, Vibe Skov, 268143

COEXISTENCE OF Β-THALASSEMIA WITH IVS-2-654 MUTATION AND ESSENTIAL THROMBOCYTHEMIA

EHA Library, Jian HUANG, 268144

EPIDEMIOLOGICAL DATA ON MYELOFIBROSIS IN ALBANIAN POPULATION ( 1999-2018)

EHA Library, Adela Perolla, 268145

AN UNCOMMON CASE OF SECONDARY MYELOFIBROSIS RELAPSING AS MYELOID SARCOMA

EHA Library, Francesca Perutelli, 268146

COMPARISON BETWEEN MANUAL AND AUTOMATED PLATELET COUNTS OF ADULT PATIENTS WITH THROMBOCYTOPENIA AT ST. PAUL’S HOSPITAL ILOILO (SPHI), PHILIPPINES

EHA Library, Lheymac2019 agreda- cadete, 268147

DOES ELTROMBOPAG CHANGE THE CHRONIC ITP COURSE IN CHILDREN, ESPECIALLY YOUNG?

EHA Library, Marek Karwacki, 268148

CUTANEOUS HEMORRHAGE TYPES AS SUPPORTIVE FACTORS FOR PREDICTING CHRONIC IMMUNE THROMBOCYTOPENIA IN CHILDREN

EHA Library, nechama sharon, 268149

A SERVICE IMPROVEMENT RE-AUDIT: THE ROLE OF THE 4T CRITERIA IN ASSESSING THE NEED FOR A HIT ASSAY IN A TERTIARY HOSPITAL SETTING

EHA Library, Ghada ElGohary, 268150